-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
Long-term follow-up of human papillomavirus vaccine efficacy
Matti Lehtinen
Editorial: Clinical Investigation
-
Long-term follow-up of human papillomavirus vaccine efficacy
Matti Lehtinen
Editorial: Clinical Investigation
-
Long-term follow-up of human papillomavirus vaccine efficacy
Matti Lehtinen
Editorial: Clinical Investigation
-
Long-term follow-up of human papillomavirus vaccine efficacy
Matti Lehtinen
Editorial: Clinical Investigation
-
Long-term follow-up of human papillomavirus vaccine efficacy
Matti Lehtinen
Editorial: Clinical Investigation
-
Long-term follow-up of human papillomavirus vaccine efficacy
Matti Lehtinen
Editorial: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Brad Spellberg
Brad Spellberg
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Brad Spellberg
Brad Spellberg
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Brad Spellberg
Brad Spellberg
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Brad Spellberg
Brad Spellberg
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Brad Spellberg
Brad Spellberg
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Brad Spellberg
Brad Spellberg
Interview: Clinical Investigation